Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation

BACKGROUND: Frailty predicts poorer outcomes and decreased anticoagulation use in patients with nonvalvular atrial fibrillation. We sought to assess the effectiveness and safety of apixaban, dabigatran and rivaroxaban versus warfarin in frail nonvalvular atrial fibrillation patients. METHODS AND RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Brandon K., Sood, Nitesh A., Bunz, Thomas J., Coleman, Craig I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015429/
https://www.ncbi.nlm.nih.gov/pubmed/29654196
http://dx.doi.org/10.1161/JAHA.118.008643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015429/
https://www.ncbi.nlm.nih.gov/pubmed/29654196
http://dx.doi.org/10.1161/JAHA.118.008643

Ejemplares similares